The European Society of Gene and Cell Therapy (ESGCT) promotes basic and clinical research in
gene therapy, cell therapy and genetic vaccines by facilitating education, the exchange of
information and technology, and by serving as a professional adviser to stakeholder communities
and regulatory bodies in Europe.

 

 

Icon
UPDATE
 

ESGCT Spring School, Granada, Spain

Registration for the ESGCT Spring School is now open. More information on the programme
and practicalities are available on the Spring School page in the congress section.

24th Annual Congress in collaboration with the ISSCR: Recordings of the Plenary Sessions

Presentations are available to meeting attendees only. To access these presentations, please see the login information sent in an email from the ISSCR. If you did not receive this email, please check your spam filter or email isscr@isscr.org.

 PLENARY SESSION RECORDINGS

Latest News

Feng Zhang Discusses CRISPR and Future of Gene Editing in Interview in Human Gene Therapy

Read more

Kite Announces Positive Topline Primary Results of Axicabtagene Ciloleucel from First Pivotal CAR-T Trial in Patients with Aggressive Non-Hodgkin Lymphoma

Read more

New gene therapy success in a rare disease of the immune system: Wiskott-Aldrich syndrome

Read more

First stem-cell therapy recommended for approval in EU

Read more

ESGCT Award Winners at the 22nd Annual Meeting of the German Society for Gene Therapy DG GT

Read more